Latest News

New Client Win: Aagami Appointed to Secure Strategic Partnerships, Licensing, and Funding for Phase 3-Ready Cardiovascular Asset Targeting Atrial Fibrillation

CHICAGO, IL — July 2, 2026 — Aagami, Inc., a premier global life sciences consulting firm, today announced it has been appointed by an innova...

Published : 02 Jul 2026

Read More

New Client Win: Aagami Appointed by Innovative Biopharmaceutical Company to Secure Strategic Partnering and Global Licensing for Advanced Oncology and Rare Disease Pipelines

CHICAGO, IL — July 1, 2026 — Aagami, Inc., a premier global life sciences consulting firm, is proud to announce a new client win. An innovati...

Published : 01 Jul 2026

Read More

Aagami Appointed to Secure Exclusive Regional Partners in Japan and South Korea for Advanced Neurosurgical MRI and Robotics

CHICAGO, IL — June 19, 2026 — Marking its second major East Asian partnering mandate in the medical technology sector this week, Aagami, Inc....

Published : 19 Jun 2026

Read More

Aagami Secures New Strategic Assignment from existing client to expand into Japan and Korea for Advanced Urological MRI and Prostate Interventions

CHICAGO, IL — June 18, 2026 — Aagami, Inc. has received a new strategic assignment from a highly valued existing client. Under this expanded ...

Published : 18 Jun 2026

Read More

New Client Win: Aagami Selected to Lead Outlicensing for Key Biosimilars in Japan and South Korea

Aagami is proud to announce a New Client Win. We have been officially appointed by a prominent, rapidly growing global pharmaceutical company to ...

Published : 16 Jun 2026

Read More

Aagami Wins New Project from French Biotech Client

Aagami has been awarded a new mandate by its French biotech client to support the out-licensing of NFL-101, the client’s lead Phase 3 asset for smok...

Published : 01 Jun 2026

Read More

Aagami Secures Global Strategic Advisory Mandate from existing Client for Phase 3-Ready Cardiovascular Biologic

Aagami, Inc., a boutique global life science strategic consulting firm, has been awarded an exclusive, unrestricted global advisory assignment by a pr...

Published : 01 Jun 2026

Read More

New Client Win: Aagami Secured by French Pharma Innovator with Needle-Free Drug Auto-Injector

Aagami is pleased to announce a new strategic client win with a pioneering France-headquartered pharmaceutical company. Under this newly signed mandat...

Published : 27 Mar 2026

Read More

Aagami has received contract extension from California client for partnering of their first in class eye drop to reverse cataract non-invasively

Our clients’ affinity for us continues to grow. Aagami has received another contract extension. The client is developing small molecule eye dro...

Published : 22 Mar 2026

Read More

New Assignment: Outlicensing and Distribution rights for Marketed Dental gel addressing Periodontitis, Gingivitis, & Caries

Aagami has received a new assignment from an existing client, to support regional/global partnering initiative for their Marketed Dental gel...

Published : 20 Mar 2026

Read More